Summary:
- Roche announced the launch of a new artificial intelligence (AI)-powered digital pathology solution called uPath HER2 (HER2) Dual ISH Image Analysis.
- The solution is designed to help pathologists accurately and efficiently assess HER2 status in breast cancer samples, which is a crucial step in determining the appropriate treatment for patients.
- The AI-powered image analysis tool is expected to improve the consistency and accuracy of HER2 testing, ultimately leading to better patient outcomes.